Moderna shares tank after FDA delays COVID vaccine for 12- to 17-year-olds
November 01, 2021 at 11:35 AM EDT
Shares in Moderna Inc. dropped at least 5% as trading opened Monday after a delay in the decision to approve the COVID-19 vaccine for adolescents ages 12-17.
